$Cadrenal Therapeutics (CVKD.US)$ In a report released today...

Biff commented on a stock · Mar 13 16:15

$Cadrenal Therapeutics(CVKD.US)$ In a report released today, Robert LeBoyer from Noble Financial maintained a Buy rating on Cadrenal Therapeutics, Inc. (CVKD – Research Report), with a price target of $4.00. The company’s shares closed yesterday at $0.58.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3608 Views

Comment

Biff

I don't acknowledge Bashers anymore! They Will be Blocked They're a waste of Time!

1221Followers

474Following

11KVisitors